Biomedical research has a fragmentation problem.
A thousand papers study oxidative stress in neurodegeneration. A thousand more study gut dysbiosis. Others examine metal dyshomeostasis, or neuroinflammation, or α-synuclein aggregation. Each one is methodologically rigorous. Each one adds one more tile to a mosaic. But nobody assembles the mosaic into a picture.
The result is a research landscape where mechanisms are studied in isolation, therapeutic hypotheses target downstream pathology because upstream logic was never assembled, and practitioners don't know which findings apply to their condition. We have precision in the pieces and incoherence in the whole.
When Kimberly and I sat down to tackle Parkinson's disease in late 2025, we didn't do a literature review. We didn't form a consensus panel. We used a structured method designed specifically to solve this fragmentation problem.
We called it the Microbiome Medicine Roundtable.
The method worked so well—producing five peer-reviewed papers with DOIs, a novel therapeutic hypothesis, and a published journal issue in eight weeks with two people—that I felt obligated to document exactly how we did it. That documentation became a formal paper published in the inaugural issue of the Microbiome Medicine Journal.
What I want to explain here is why the method exists, how it works, and why it matters for your condition—whatever that condition is.
Why fragmentation happens
Biomedical research is organized by specialty. You have gastroenterologists studying the microbiome, neurologists studying the brain, immunologists studying immunity, and biochemists studying metal handling. Each specialty has its own journals, conferences, funding streams, and career incentives. They speak different technical languages. They use different model systems. They cite different foundational papers.
This makes sense from an organizational standpoint. Depth requires specialization.
But diseases don't respect specialty boundaries. Parkinson's disease is not purely neurological. It is a systems disease spanning neurobiology, immunology, microbiology, metallomics, and host genetics. The mechanisms cannot be fully understood within any single specialty. They can only be understood by integrating across specialties.
The fragmentation of research mirrors the fragmentation of our understanding. Until you bring the pieces together, they stay pieces.
The Roundtable method: three principles
The method rests on three principles that forced us to think differently.
First: upstream causation. Start with the environmental pressure or molecular disturbance that initiates pathology, not the clinical symptoms or downstream pathology. Ask what selects for disease, not what disease looks like. This reframes the entire causal story. Instead of asking "why do Parkinson's patients have dysbiosis?" you ask "what gut dysbiosis is caused by the same upstream disturbance that causes neurodegeneration?" The second question leads you to mechanisms.
Second: mechanistic coherence. Every proposed connection must rest on a biological mechanism. Correlation is noted but not sufficient. If A influences B, we must specify the molecular or ecological pathway by which this happens. Vague language is forbidden. We cannot say "inflammation drives neurodegeneration." We must say which specific inflammatory mediators, which cellular targets, which feedback loops, and why those feedbacks matter. This discipline eliminates a lot of speculative dead-ends but forces the reasoning to be testable.
Third: cross-domain integration. At least three specialized domains must be threaded together to form the unified framework. For Parkinson's, this was pigmentation biology (previously completely absent from the literature on neurodegeneration), metallomics, microbiology, and neurobiology. The act of threading together domains that don't normally talk to each other is where novel insights emerge. A pigmentation biologist and a microbiologist speaking past each other in the literature both become sources of mechanism when they are read in light of the same upstream pressure.
These three principles sound simple. In practice, they are ruthlessly constraining. They eliminate casual speculation, force rigor, and often lead to unexpected directions.
How the method produces output
The Roundtable process moves through stages.
We begin with a question: what single upstream disturbance could explain multiple seemingly unrelated observations? For Parkinson's, the hypothesis was metal dyshomeostasis. Not a fact, but a starting proposition to test against the literature.
We then search for evidence that supports or contradicts this hypothesis across multiple domains. We look for metal exposure data, ferroptosis mechanisms, microbial ecology in metal-contaminated environments, immune consequences of dysbiosis, and pigmentation biology. We note what fits and what doesn't.
As patterns emerge, we generate testable predictions. If metal dyshomeostasis is upstream, then:
- Metal-exposed individuals should show elevated neurodegeneration risk (supported).
- Parkinson's-associated microbes should be metal-resistant and inflammation-promoting (supported).
- Genetic variants affecting metal handling should modify Parkinson's risk (supported).
- Interventions that restore metal homeostasis should reduce neurodegeneration in preclinical models (supported).
These predictions are not just interesting ideas. They are the bridge between mechanistic explanation and experimental validation. A prediction that cannot be tested experimentally is a speculative dead-end.
The output is a unified mechanistic framework that connects upstream pressure to clinical phenotype through explicit causal steps, each grounded in established biology and each generating testable predictions. That framework then forms the foundation for proposing novel interventions that would be invisible if the mechanisms were still fragmented.
Why this matters
The Roundtable method solves three practical problems.
It produces intellectual property with clear causal logic. When you pitch investors or regulatory bodies, you need more than "here are five relevant papers by different groups." You need a coherent story: this is what initiates the disease, this is how the microbiome amplifies it, this is why this intervention could reverse it. The Roundtable delivers that story.
It generates novel hypotheses from existing evidence. We did not discover new biological facts. The published evidence on metallomics, ferroptosis, pigmentation biology, and microbiology already existed. What didn't exist was the integration. The moment you thread them together under the constraint of mechanistic causation, new hypotheses emerge automatically. The melanotan hypothesis for Parkinson's was not hidden in the literature. It was invisible until three domains were brought into conversation.
It deprioritizes dead-ends early. In a fragmented research landscape, you can spend years chasing mechanisms that seem plausible in isolation but don't fit when integrated across domains. The constraint of cross-domain coherence kills weak ideas quickly and directs effort toward mechanisms that are robust enough to span multiple specialties.
What comes next
The Parkinson's case study demonstrated the method with a single, complex disease. The same approach applies anywhere that mechanistic fragmentation is the limiting factor.
For my team, that means any condition where the research has been siloed, where the microbiome appears relevant but has never been integrated with the immunology or the genetics or the metabolomics, where the therapeutic pipeline is stuck on symptomatic targets because nobody assembled the upstream logic.
Endometriosis. Chronic kidney disease. Autism spectrum disorders. Inflammatory bowel disease. Multiple sclerosis. Many of these conditions have the same structure as Parkinson's did before the Roundtable: fragmented observations, multiple competing hypotheses, no unified mechanism.
The method is reproducible. It doesn't require new biology. It requires discipline: upstream thinking, mechanistic rigor, and the courage to draw connections across specialties that don't normally speak to each other.
If you have a condition that feels like this—fragmented, therapeutic dead-ended, waiting for the moment when someone integrates the pieces—the Roundtable exists to provide that integration.
Learn more about how the Roundtable works, or explore the Triangulation Method that grounds Roundtable reasoning. The formal methodology is published in Microbiome Medicine Journal Vol I Issue I.